Highlights Basic and Translational Science
|
|
- Rudolph Owens
- 5 years ago
- Views:
Transcription
1 Highlights Basic and Translational Science Excitation-Contraction Coupling Frank R. Heinzel Medical University of Graz, Austria
2 Acknowledgments Ole Kemi, University of Glasgow, UK Julia Sprenger, University of Göttingen, Germany Georgios Kararigas, Charite University Hospital, Berlin, Germany Constantijn Franssen, VUmc Amsterdam, The Netherlands Judit Kalász, University of Debrecen, Hungary Uwe Primessnig and Senka Ljubojevic, University of Graz, Austria László Nagy, University of Debrecen, Hungary
3 Overview Gender aspects in ECC PMCA1 and 4 in the heart Cardiomyocyte Ca 2+ changes in HFPEF Effect of exercise on Ca 2+ alternans post MI Local camp regulation in SERCA microdomain L-OR-2828, a new Ca 2+ sensitizer
4 Background: Gender Electrophysiology Women have a higher resting heart rate than men independent of differences in autonomous tone (Jose and Collison 1970, Burke et al. 1996). Women have a slightly longer QT interval (~20 ms longer than in men) (Bazett, 1920; Molnar et al. 1996). Women are more likely to develop TdP tachycardias (Lehmann et al. 1996, Makkar et al. 1993)
5 Sex-specific ventricular transcriptional profiles and calcium current densities in patients with dilated cardiomyopathy G Kararigas, C E Molina, H Summer, P E Molina, I Julia, I Baczko, S Golz, R Hetzer, V Regitz-Zagrosek Charite University Hospital - Berlin - Germany, 2ICCC-CSIC, Hospital Santa Creu i Sant Pau - Barcelona - Spain, 3Bayer HealthCare - Wuppertal - Germany, 4Hospital de la Santa Creu i Sant Pau, Department of Cardiac Surgery - Barcelona - Spain, 5University of Szeged - Szeged - Hungary, 6German Heart Institute Berlin - Berlin - Germany,
6 Gender-Specific Gene Regulation in Heart Failure Biopsies: DCM: N= 5 female ; N=5 male NF : N=8 female; N=10 male N regulated gene clusters vs. non-failing up down Single gene differential expression False discovery rate (FDR)-adjusted P < 0.01 LV samples of men (n = 5) and women (n = 5) with end-stage non-ischaemic DCM were compared with LV samples of men (n = 10) and women (n = 8) with no cardiovascular disorder G Kararigas
7 Gender-Specific Regulation of Ca 2+ Signalling Genes 5-HT 6 receptor Prostagl. 6 receptor Purinergic P2X ion channel PLC β2 T-type Ca channel Although Ca 2+ signalling was induced in both sexes, male tissues had a significantly higher induction with a ca. 30% of genes encoding ion channels, accessory beta subunits and regulatory proteins being more induced in male than in female tissues. G Kararigas
8 Higher L-type Ca 2+ Current Density in Males with HF No sex differences in SR Ca 2+ load. G Kararigas
9 Previous Study Verkerk et al. Int Heart J. 2005;46: Etiology : DCM G Kararigas
10 Summary Sex-specific ventricular transcriptional profiles and calcium current densities in patients with dilated cardiomyopathy The study offers a novel sex-specific aspect of gene regulation in the human failing heart. L-type Ca 2+ channel regulation in heart failure is complex and includes gender-specific differences in function. G Kararigas
11 Independent roles for PMCA1 and 4 in the development of left ventricular hypertrophy and failure N Stafford, M Zi, M Shaheen, TM Mohamed, S Cook, S Prehar, L Neyses, EJ Cartwright University of Manchester, UK
12 Background Both isoforms 1 and 4 of PMCA are downregulated in failing human and rodent hearts. PMCA4 modulates cardiac hypertrophy regulates β-adrenergic signalling Cartwright,, Neyses. Sci China Life Sci. 2011;54:691-8.
13 Aim Study the role of PMCA1 and PMCA4 in cardiac remodeling Methods Generated cardiomyocyte-specific knockout mice PMCA1 -/- PMCA4 -/- PMCA1+4 -/- TAC banding (2 weeks), echocard., morphometry, cardiac myocyte Ca2+ transients N Stafford
14 Results: Baseline Morphology TAC (2 wks) (vs. WT TAC) Function/ Histology PMCA1 -/- phenotype change rapidly decomp. hypertrophy congestion, apopt. extensive fibrosis slowed CaT decay PMCA4 -/- phenotype change strongly attenuated hypertrophy (-86% vs. WT TAC) preserved syst./diast. function PMCA1+4 -/- phenotype change slight hypertrophy preserved EF reduced firbrosis 2% of cytosolic Ca2+ extrusion (PMCA1) N Stafford
15 Summary Novel evidence of isoform-specific roles for PMCA1 and 4 in cardiac muscle, both capable of influencing the pathological progression of cardiac hypertrophy. PMCA1 may be critical in adapting to the increased demands placed on the heart during pressure overload, whilst the inhibition of PMCA4 may negate the need to adapt altogether and could be a potential target for future antihypertrophic therapies. N Stafford
16 Impaired cardiomyocyte relaxation in a rat model of compensated renal failure and diastolic heart failure U. Primessnig, S. Pfeiffer, P. Wakula, M.Stipacek, T. Rau, T. Stojakovic, B. Pieske, F.R. Heinzel Medical University of Graz, Austria
17 Aim to study cellular mechanisms of contractile dysfunction in a model of diastolic heart failure U. Primessnig
18 Model subtotal (5/6) nephrectomy in rats U. Primessnig
19 Results renal impairment, hypertension, hypertrophy U. Primessnig
20 Results HFPEF U. Primessnig
21 Results LV cardiomyocyte : slowed relaxation NXT U. Primessnig
22 Results LV cardiomyocyte : slowed Ca decay U. Primessnig
23 TAU (sec.) Results LV cardiomyocyte : reduced NCX forward U. Primessnig
24 Results NCX1 protein expression U. Primessnig
25 Summary Subtotal nephrectomy (NXT) in rats induces stable compensated renal failure and heart failure with preserved ejection fraction (HFPEF). Ca2+- mediated relaxation is prolonged at the level of cardiomyocytes. NCX1 forward mode activity is reduced despite increased NCX protein expression suggesting increased reverse mode activity of the NCX. U. Primessnig
26 Cardiomyocyte Contractile and Ca 2+ Handling Breakdown at High Stimulation Frequencies in Post-Myocardial Infarction Heart failure is Reversed by Exercise Training Ole J Kemi, Alex S. Johnston, Michael Dunne, Godfrey Smith University of Glasgow, UK
27 Background Alternans indicates beat-to-beat oscillation in contraction amplitude, Ca 2+ transient amplitude and/or action potential duration Alternans occurs at increased (pacing) frequencies. Propensity for alternans has been associated with an increased risk of arrhythmias. Alternans is observed with myocardial ischemia.
28 Model LAD ligation in Wistar rats Exercise training (TRN): intensity-controlled aerobic treadmill running at 90% of maximal oxygen uptake initiated 1-month post-mi, for a period of 2-3 months. Sacrifice : 3-4 months post MI Isolation of LV cardiomyocytes, Ca2+ indicators Fura-2 or Fluo-4 O. Kemi
29 Results : intracellular Ca 2+ transients O. Kemi
30 Results : Ca 2+ sparks and waves WAVES SPARKS O. Kemi
31 Results : Ca 2+ alternans O. Kemi
32 Summary Exercise training partly, but not fully reversed cardiomyocyte Ca 2+ handling abnormalities observed during increasing twitch-stimulation frequencies in post-mi HF. This suggests a mechanism that contributes to the improved reserve capacity and reduced arrhythmia susceptibility in failing hearts following exercise training. Mechanism: Ca 2+ alternans depends on SR [Ca 2+ ] fluctuations. SERCA function? [Diaz et al. 2004; CircRes] O. Kemi
33 Local camp dynamics in the SERCA2 compartment Studied by a targeted FRET biosensor Julia U. Sprenger, Viacheslav O. Nikolaev University of Göttingen, Germany
34 Background: Localized camp-regulation by phosphodiesterases (PDEs) in the heart Fischmeister R (2006). Circ Res 99:
35 Aim To understand camp-regulation in the SERCA2 microdomain! Julia U. Sprenger, Viacheslav O. Nikolaev
36 Methods transgenic mouse expressing a newly camp FRET biosensor targeted to SERCA2 via phospholamban (Epac1-camps-PLN) isolated cardiomyocytes comparison of local camp dynamics with those in the bulk cytosol 8 weeks post TAC and Sham J. Sprenger
37 Results FRET-sensor expression In Epac1-PLN mice, Epac1-PLN co-localizes with SERCA J. Sprenger
38 Results Differential β-adrenergic stimulation Baseline β1-adrenergic receptor stimulation led to a stronger increase of local camp levels at SERCA2 microdomain β2-adrenergic receptor stimulation had almost no impact on camp levels in the SERCA2 microdomain J. Sprenger
39 Results PDE isoforms at SERCA microdomain At baseline, FRET measurements reveal the predominant role of PDE4 [and PDE3] in the SERCA2 compartment.
40 Results Saturation of SERCA microdomain With beta-adrenergic pre-stimulation, differences in PDE-mediated functional compartmentation are alleviated J. Sprenger
41 Results Changes with TAC hypertrophy In 8 weeks TAC vs. Sham, 1. local SERCA PDE4 activity is reduced 2. no difference in PDE4 activity between cytosol and SERCA 3. total PDE activity in the cytosol is unchanged SHAM TAC J. Sprenger
42 Summary FRET revealed a stronger increase of local camp levels in the SERCA compartment as compared to the bulk cytosol after beta adrenergic stimulation a predominant role of PDE4 in the SERCA2 compartment at the basal state a decreased PDE4 signal in the SERCA2 compartment during hypertrophy Conclusions: A transgenic Epac1-camps-PLN mouse was successfully generated FRET measurements revealed distinct camp dynamics in the SERCA2 microdomain compared to the bulk cytosol and their alterations in cardiac hypertrophy J. Sprenger
43 Ca 2+ -sensitizing effects of OR in permeabilized cardiomyocytes UD MHSC Institute of Cardiology Division of Clinical Physiology, Debrecen, HU László Nagy
44 Background Levosimedan increases cardiac inotropy by increasing myofilament Sensitivity. Levosimedan has PDE-inhibiting effects and may cause hypotension.
45 Aim To assess the effects of a new putative Ca2+ sensitizer on cardiomyocyte myofilament sensitivity L. Nagy
46 Methods left ventricular tissue samples obtained from guinea pigs of either sex ( g), as well as from failing human hearts with dilated cardiomyopathy L. Nagy
47 L-OR 2828 (but not R-OR 2828) increases myofilament sensitivity L. Nagy
48 L-OR 2828 (but not R-OR 2828) increases myofilament sensitivity Guinea pig VM Human VM EC50 = μm. L. Nagy
49 Summary L-OR-2828 is a positive inotropic agent and Ca2+-sensitizer. The magnitude of the Ca2+-sensitizing effect of L-OR appeared to be comparable to that of levosimendan as seen in previous studies. The EC 50 of L-OR-2828 (2.435 μm) was lower than the EC 50 reported for levosimedan (9.19±2.42 nm, Lancaster et al. Eur J Pharmacol 1997) L. Nagy
Supplementary Figures Supplementary Figure 1. Development of the camp biosensor targeted to the SERCA2a microdomain.
Supplementary Figures Supplementary Figure 1. Development of the camp biosensor targeted to the SERCA2a microdomain. A B C (A) Schematic representation of the new constructs designed for local camp imaging.
More informationIn Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison
In Vivo Animal Models of Heart Disease Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison Why Animal Models of Disease? Heart Failure (HF) Leading cause of morbidity and mortality
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationExercise in Adverse Cardiac Remodeling: of Mice and Men
Exercise in Adverse Cardiac Remodeling: of Mice and Men 17-01-2013 Dirk J Duncker Experimental Cardiology, Cardiology, Thoraxcenter Cardiovascular Research Institute COEUR Erasmus MC, University Medical
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST A potential anti-hypertrophic agent Riham Abouleisa Cardiac hypertrophy is a compensatory response to maintain function during increased stress. A sustained hypertrophic
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Disclosures: Research grants & clinical trials (Gilead), honoraria & clinical trials (Berlin-Chemie/Menarini) Ranolazine in Heart Failure with Preserved Ejection Fraction
More informationDiagnosis is it really Heart Failure?
ESC Congress Munich - 25-29 August 2012 Heart Failure with Preserved Ejection Fraction From Bench to Bedside Diagnosis is it really Heart Failure? Prof. Burkert Pieske Department of Cardiology Med.University
More informationSarcoplasmic Reticulum Ca Homeostasis and Heart Failure
Sarcoplasmic Reticulum Ca Homeostasis and Heart Failure Aleksey V. Zima and Dmitry Terentyev SR Ca Regulation in Heart Heart function vitally relies on precisely controlled intracellular Ca homeostasis
More informationEffects of reference compounds on impedance signals from stem cellderived human cardiomyocytes
Effects of reference compounds on impedance signals from stem cellderived human cardiomyocytes Herbert M. Himmel, Safety Pharmacology, Bayer Pharma AG, Wuppertal, Germany SPS Webinar Cardiac Safety Testing
More informationIndex. A Action potential duration, increased, by decreases in sodium current,
Heart Failure Clin 1 (2005) 313 319 Index Note: Page numbers of article titles are in boldface type. A Action potential duration, increased, by decreases in sodium current, 201 202 Adenylyl cyclase, overexpression
More informationNew drugs on the horizon for heart failure: CaMK antagonists
New drugs on the horizon for heart failure: CaMK antagonists (Lars S. Maier) Gerd Hasenfuss Disclosure Information: No relationship exists related to this presentation Dept. of Cardiology and Pneumology,
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationGene annotation for heart rhythm. 1. Control of heart rate 2. Action Potential 3. Ion channels and transporters 4. Arrhythmia 5.
Gene annotation for heart rhythm 1. Control of heart rate 2. Action Potential 3. Ion channels and transporters 4. Arrhythmia 5. EC coupling Control of heart rate Autonomic regulation of heart function
More informationDeclaration of conflict of interest. I have nothing to disclose.
Declaration of conflict of interest I have nothing to disclose. Left Bundle branch block in HF: DO GENETICS MATTER? Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University
More informationAtrial fibrillation in the ICU
Atrial fibrillation in the ICU Atrial fibrillation Preexisting or incident (new onset) among nearly one in three critically ill patients Formation of arrhythogenic substrate usually fibrosis (CHF, hypertension,
More informationPatient Susceptibilities in Preclinical Drug Safety Assessment
Patient Susceptibilities in Preclinical Drug Safety Assessment B. R. Berridge GlaxoSmithKline ILAR Roundtable October, 2017 Animal studies represent an apical preclinical modeling system in drug development
More informationHighlights of the Congress - Basic Science -
Highlights of the Congress - Basic Science - Myocyte function and ion homeostasis Frank R. Heinzel, Graz Predisposition Trigger Cardiomyocyte Excitability/ Arrhythmias Na + ECC channels pumps Ca 2+ receptors
More informationDiastolic Function. Rick Nishimura Leighton Professor of CV Diseases Mayo Clinic No Disclosures
Diastolic Function Rick Nishimura Leighton Professor of CV Diseases Mayo Clinic No Disclosures Heart = Pump Heart Failure Systolic Dysfunction Diastolic Dysfunction Diastole is a complex sequence of multiple
More information1. Cardiomyocytes and nonmyocyte. 2. Extracellular Matrix 3. Vessels שאלה 1. Pathobiology of Heart Failure Molecular and Cellular Mechanism
Pathobiology of Heart Failure Molecular and Cellular Mechanism Jonathan Leor Neufeld Cardiac Research Institute Tel-Aviv University Sheba Medical Center, Tel-Hashomer שאלה 1 התא הנפוץ ביותר (75%~) בלב
More informationDrugs Used in Heart Failure. Assistant Prof. Dr. Najlaa Saadi PhD pharmacology Faculty of Pharmacy University of Philadelphia
Drugs Used in Heart Failure Assistant Prof. Dr. Najlaa Saadi PhD pharmacology Faculty of Pharmacy University of Philadelphia Heart Failure Heart failure (HF), occurs when cardiac output is inadequate to
More informationCardiac Gene Therapy: Beyond the Mouse. David M Kaye Heart Failure Research Group Baker IDI, Melbourne, AUSTRALIA
Cardiac Gene Therapy: Beyond the Mouse David M Kaye Heart Failure Research Group Baker IDI, Melbourne, AUSTRALIA Presenter Disclosure Information FINANCIAL DISCLOSURE: Equity: Osprey Medical Grants/Research
More informationCardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.
Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.
More informationEpac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses
Research article Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses Satoshi Okumura, 1,2 Takayuki Fujita, 1 Wenqian Cai, 1 Meihua Jin, 1 Iyuki Namekata, 3 Yasumasa
More informationLevosimendan, a New Inotropic and Vasodilator Agent Wolfgang G. Toller, M.D.,* Christian Stranz, M.D.
REVIEW ARTICLES David C. Warltier, M.D., Ph.D., Editor Anesthesiology 2006; 104:556 69 2006 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Levosimendan, a New Inotropic
More informationExcitation-Contraction Coupling And Cardiac Contractile Force (Developments In Cardiovascular Medicine) By Donald Bers READ ONLINE
Excitation-Contraction Coupling And Cardiac Contractile Force (Developments In Cardiovascular Medicine) By Donald Bers READ ONLINE If you are searching for a book Excitation-Contraction Coupling and Cardiac
More informationHEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
HEART FAILURE PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Understand the effects of heart failure in the body
More informationRegulation of intracellular Na 1 in health and disease: pathophysiological mechanisms and implications for treatment
OPEN ACCESS Review article Regulation of intracellular 1 in health and disease: pathophysiological mechanisms and implications for treatment Raffaele Coppini 1, *, Cecilia Ferrantini 2, Luca Mazzoni 1,
More informationAberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice
Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice Elaine Wan, Jeffrey Adams, Richard L. Weinberg, Alexander N. Katchman, Joseph Bayne, Sergey I. Zakharov, Lin Yang, John P. Morrow,
More informationCardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007
Cardiac Output MCQ Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University 2007 90- Guided by Ohm's law when : a- Cardiac output = 5.6 L/min. b- Systolic and diastolic BP
More informationAge-related changes in cardiovascular system. Dr. Rehab Gwada
Age-related changes in cardiovascular system Dr. Rehab Gwada Objectives explain the main structural and functional changes in cardiovascular system associated with normal aging Introduction aging results
More informationDiastolic Heart Failure
Diastolic Heart Failure Presented by: Robert Roberts, M.D., FRCPC, MACC, FAHA, FRSC Professor of Medicine and Chair ISCTR University of Arizona, College of Medicine Phoenix Scientist Emeritus and Advisor,
More informationHYPERTENSION AND HEART FAILURE
HYPERTENSION AND HEART FAILURE Kenya Cardiac Society Symposium Feb 2017 Dr Jeilan Mohamed No conflict of interests . Geoffrey, 45 yr old hypertensive office worker male from Nairobi, has just watched his
More informationIntravenous Inotropic Support an Overview
Intravenous Inotropic Support an Overview Shaul Atar, MD Western Galilee Medical Center, Nahariya Affiliated with the Faculty of Medicine of the Galilee, Safed, Israel INOTROPES in Acute HF (not vasopressors)
More informationSelected age-associated changes in the cardiovascular system
Selected age-associated changes in the cardiovascular system Tamara Harris, M.D., M.S. Chief, Interdisciplinary Studies of Aging Acting Co-Chief, Laboratory of Epidemiology and Population Sciences Intramural
More informationGenetic ablation of Acp1 (Lmptp) in mice prevents heart failure
Genetic ablation of Acp1 (Lmptp) in mice prevents heart failure Coralie Poizat, Ph.D. Director, Cardiovascular Research Program KFSHRC-Riyadh Saudi Heart Failure Working Group Jeddah, 5 December 2015 Cardiovascular
More informationΔακτυλίτιδα και Ινότροπα Φάρμακα στην Καρδιακή Ανεπάρκεια. Ι.Κανονίδης
Δακτυλίτιδα και Ινότροπα Φάρμακα στην Καρδιακή Ανεπάρκεια Ι.Κανονίδης Cardiac Glycosides Chronic Congestive Heart Failure DIGOXIN Na-K ATPase Na + K + Na-Ca Exchange Na + Ca ++ Ca ++ K + Na + Myofilaments
More informationExploring the Reno-Cardiac Connection. Protect your kidneys save your heart
Exploring the Reno-Cardiac Connection Protect your kidneys save your heart Heart Failure: a major health care problem ~23 million people with heart failure worldwide Heart failure increases progressively
More informationMathematical Model of the Electromechanical Heart Contractile System Regulatory Subsystem Physiological Considerations
Physiol. Res. 50: 425-432, 2001 Mathematical Model of the Electromechanical Heart Contractile System Regulatory Subsystem Physiological Considerations M. MLČEK, J. NEUMANN, O. KITTNAR, V. NOVÁK Institute
More informationBasics of skeletal muscle electrophysiology. Tóth András, PhD
Basics of skeletal muscle electrophysiology Tóth András, PhD Topics Structure Contraction and relaxation Activation Excitation-contraction coupling Action potential Ion channels* Calcium homeostasis Structure
More informationOptimal Adrenergic Blockades in Heart Failure. Jae-Joong Kim MD, PhD Asan Medical Center, University of Ulsan, Seoul, Korea
Optimal Adrenergic Blockades in Heart Failure Jae-Joong Kim MD, PhD Asan Medical Center, University of Ulsan, Seoul, Korea Contents Harmful effects of adrenergic system in heart failure Clinical studies
More informationInternational Graduate Research Programme in Cardiovascular Science
1 International Graduate Research Programme in Cardiovascular Science This work has been supported by the European Community s Sixth Framework Programme under grant agreement n LSHM-CT-2005-01883 EUGeneHeart.
More informationRemodeling the failing heart: : the biology and future treatment options
Remodeling the failing heart: : the biology and future treatment options J-L Balligand (UCL-Brussels, BE) jl.balligand@uclouvain.be Myocardial remodeling: definitions phenotypic plasticity : remodeling
More informationQUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY:
QUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY: First, there are two possibilities: I) It is not known, if the patient (subject) presented
More informationEvolving pharmacologic antiarrhythmic treatment targets Ready for clinical practice?
Evolving pharmacologic antiarrhythmic treatment targets Ready for clinical practice? David O. Arnar MD PhD EMPH Landspitali The National University Hospital of Iceland, Reykjavik Disclosures Consultant
More informationThe Cardiovascular System
Chapter 18 Part A The Cardiovascular System 1/19/16 1 Annie Leibovitz/Contact Press Images Similarities of Cardiac and Skeletal Muscle RMP Ion concentration Deploarization Action Potential Repolarization
More informationCollin County Community College
Collin County Community College BIOL. 2402 Anatomy & Physiology WEEK 5 The Heart 1 The Heart Beat and the EKG 2 1 The Heart Beat and the EKG P-wave = Atrial depolarization QRS-wave = Ventricular depolarization
More informationCh 12: Muscles sarcolemma, t-tubules, sarcoplasmic reticulum, myofibrils, myofilaments, sarcomere...
Ch 12: Muscles Review micro-anatomy of muscle tissue Terminology examples: sarcolemma, t-tubules, sarcoplasmic reticulum, myofibrils, myofilaments, sarcomere... SLOs Differentiate levels of muscle structure:
More informationHeart Failure with Preserved Ejection Fraction: Mechanisms and Management
Heart Failure with Preserved Ejection Fraction: Mechanisms and Management Jay N. Cohn, M.D. Professor of Medicine Director, Rasmussen Center for Cardiovascular Disease Prevention University of Minnesota
More informationThe independent roles of PMCA1 and PMCA4 in the development and progression of left ventricular hypertrophy and failure
The independent roles of PMCA1 and PMCA4 in the development and progression of left ventricular hypertrophy and failure A thesis submitted to the University of Manchester for the degree of Doctor of Philosophy
More informationC57BL/6 Mice are More Appropriate. than BALB/C Mice in Inducing Dilated Cardiomyopathy with Short-Term Doxorubicin Treatment
Original Article C57BL/6 Mice are More Appropriate Acta Cardiol Sin 2012;28:236 240 Heart Failure & Cardiomyopathy C57BL/6 Mice are More Appropriate than BALB/C Mice in Inducing Dilated Cardiomyopathy
More informationPathophysiology: Heart Failure
Pathophysiology: Heart Failure Mat Maurer, MD Irving Assistant Professor of Medicine Outline Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology Heart Failure: Definitions
More informationLEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR?
LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR? Juan Cinca Department and Chair of Cardiology Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona
More informationDysrhythmias. Dysrythmias & Anti-Dysrhythmics. EKG Parameters. Dysrhythmias. Components of an ECG Wave. Dysrhythmias
Dysrhythmias Dysrythmias & Anti-Dysrhythmics Rhythm bad in the heart: Whitewater rafting Electrical impulses coordinate heart Reduction in Cardiac Output PEA Asystole Components of an ECG Wave EKG Parameters
More informationPhilipp Schlegel, Jan Ksienzyk, Jens Barthelmes, Uwe Haberkorn, Walter J. Koch, Hugo A. Katus, Patrick Most, Oliver J. Mueller, Philip W.J.
UniversityHospital Heidelberg Cardiac AAV6.betaARKct gene therapy ameliorates cardiac function and normalizes neurohumoral signaling in a clinically relevant large animal heart failure model Philipp Schlegel,
More informationHeart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output
Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover
More informationHFPEF Echo with Strain vs. MRI T1 Mapping
HFPEF Echo with Strain vs. MRI T1 Mapping Erik Schelbert, MD MS Director, Cardiovascular Magnetic Resonance Assistant Professor of Medicine Heart & Vascular Institute University of Pittsburgh Disclosures
More informationEHRA/EUROPACE 2011 Madrid, Spain June
EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different
More informationCardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski
Cardiac arrhythmias Janusz Witowski Department of Pathophysiology Poznan University of Medical Sciences A 68-year old man presents to the emergency department late one evening complaining of increasing
More informationAlterations in cardiomyocyte function during diastolic heart failure
Alterations in cardiomyocyte function during diastolic heart failure Attila Borbély VUmc UDMHSC, Division of Clinical Physiology, Institute of Cardiology, Debrecen, Hungary Laboratory for Physiology, ICaR-VU
More informationRestricted diffusion of ions regulates cardiac function. Fredrik Swift
Institute for Experimental Medical Research, Ullevål University Hospital Center for Heart Failure Research, University of Oslo Restricted diffusion of ions regulates cardiac function Fredrik Swift Dissertation
More informationMcHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload
McHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload Cardiac output (CO) represents the volume of blood that is delivered
More informationChapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure
Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for
More informationCKD Satellite Symposium
CKD Satellite Symposium Recommended Therapy by Heart Failure Stage AHA/ACC Task Force on Practice Guideline 2001 Natural History of Heart Failure Patients surviving % Mechanism of death Sudden death 40%
More informationIndex of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125
145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency
More informationHeart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)
Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types
More informationLCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor
The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction The Prospective comparison of ARNI with ARB on Management Of heart failure with preserved ejection
More informationChapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy
Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias
More informationTreating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment
ESC 2012 27Aug - 3Sep, 2012, Munich, Germany Treating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment Marco Metra, MD, FESC Cardiology University
More informationHeart Failure. Dr. Alia Shatanawi
Heart Failure Dr. Alia Shatanawi Left systolic dysfunction secondary to coronary artery disease is the most common cause, account to 70% of all cases. Heart Failure Heart is unable to pump sufficient blood
More informationReview of Cardiac Mechanics & Pharmacology 10/23/2016. Brent Dunworth, CRNA, MSN, MBA 1. Learning Objectives
Brent Dunworth, CRNA, MSN, MBA Associate Director of Advanced Practice Division Chief, Nurse Anesthesia Vanderbilt University Medical Center Nashville, Tennessee Learning Objectives Review the principles
More informationIs Heart Rate a Treatment Target?
Is Heart Rate a Treatment Target? M. Böhm Innere Medizin III (Kardiologie / Angiologie / Internistische Intensivmedizin) Universitätsklinikum des Saarlandes Homburg/Saar michael.boehm@uks.eu Heart Rate
More informationSecond Generation of Calcium Antagonists
Winifred G. Nayler Second Generation of Calcium Antagonists With 81 Figures and 63 Tables Springer-Verlag Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona Budapest Contents Foreword Chapter
More informationDiagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta
Diagnosis & Management of Heart Failure Abena A. Osei-Wusu, M.D. Medical Fiesta Learning Objectives: 1) Become familiar with pathogenesis of congestive heart failure. 2) Discuss clinical manifestations
More informationO O. Figure 1. Chemical structure of cardiac glycosides.
1. INTRDUCTIN 1.1 Cardiac glycosides The cardiac glycosides are an important class of naturally occurring drugs which actions include both beneficial and toxic effects on the heart, and have played an
More informationPressure-calcium relationships in perfused mouse hearts
Pressure-calcium relationships in perfused mouse hearts Guy A. MacGowan, Jonathan A. Kirk, Caroline Evans and Sanjeev G. Shroff AJP - Heart 290:2614-2624, 2006. First published Jan 13, 2006; doi:10.1152/ajpheart.00979.2005
More informationAtrial Fibrillation 10/2/2018. Depolarization & ECG. Atrial Fibrillation. Hemodynamic Consequences
Depolarization & ECG Atrial Fibrillation How to make ORDER out of CHAOS Julia Shih, VMD, DACVIM (Cardiology) October 27, 2018 Depolarization & ECG Depolarization & ECG Atrial Fibrillation Hemodynamic Consequences
More informationHeart Failure Treatments
Heart Failure Treatments Past & Present www.philippelefevre.com Background Background Chronic heart failure Drugs Mechanical Electrical Background Chronic heart failure Drugs Mechanical Electrical Sudden
More informationDiastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012
Diastolic Heart Failure Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012 Disclosures Have spoken for Merck, Sharpe and Dohme Sat on a physician advisory
More informationAssessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes. on the ACEA xcelligence RTCA CardioECR
Assessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the ACEA xcelligence RTCA CardioECR Application Note Version 2.1 / March 2018 Contents 1. Introduction 1 2. Assessment of pro-arrhythmic
More informationΒασιλική Κατσή. Καρδιολόγος ΓNA Ιπποκράτειο
Βασιλική Κατσή Καρδιολόγος ΓNA Ιπποκράτειο 40 διαφάνειες ίσως Και πρέπει και δικαιούνται ΣΥΧΝΟΤΕΡΑ 76-96% 3343 men and 4199 women followed for 25 years, no HF at baseline BP (mm Hg)
More informationYokohama City University School of Medicine Susumu Minamisawa (
Yokohama City University School of Medicine Susumu Minamisawa ( skeletal muscle cardiac muscle mitochondria Sarcoplasmic reticulum mitochondria I A T-tubule SR Free Ca 2+ T-tubule SR Opi. The Heart, 3rd
More informationTEACH Lesson Plan Manual for Herlihy s The Human Body in Health and Illness 5 th edition
TEACH Lesson Plan Manual for Herlihy s The Human Body in Health and Illness 5 th edition Chapter 17 Function of the Heart Lesson 17.1 Function of the Heart 1. Define cardiac cycle with respect to systole
More informationCardiac devices beyond pacemaker and ICD Prof. Dr. Martin Borggrefe
Cardiac devices beyond pacemaker and ICD Prof. Dr. Martin Borggrefe Mannheim CRT studies Patient selection CRT: NYHA III-IV, EF 35%, SR, QRS 120ms, LVEDD>55mm (25-45)% Non-Responder The Concept: Cardiac
More informationDiabetes and the Heart
Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital
More informationDiastolic Dysfunction: Hypertension to Hypertrophy to Heart Failure
Diastolic Dysfunction: Hypertension to Hypertrophy to Heart Failure Dr. Shelley Zieroth FRCPC Assistant Professor, Cardiology, University of Manitoba Director of Cardiac Transplant and Heart Failure Clinics
More informationGenetics of Sudden Cardiac Death. Geoffrey Pitt Ion Channel Research Unit Duke University. Disclosures: Grant funding from Medtronic.
Genetics of Sudden Cardiac Death Geoffrey Pitt Ion Channel Research Unit Duke University Disclosures: Grant funding from Medtronic Duke U N I V E R S I T Y Sudden Cardiac Death High incidence 50-100 per
More informationOutline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies
Outline Pathophysiology: Mat Maurer, MD Irving Assistant Professor of Medicine Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology : Definitions An inability of the
More informationNoninvasive Predictors of Sudden Cardiac Death
2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial
More informationDefinition of Congestive Heart Failure
Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million
More informationThe Pharmacology of Hypotension: Vasopressor Choices for HIE patients. Keliana O Mara, PharmD August 4, 2018
The Pharmacology of Hypotension: Vasopressor Choices for HIE patients Keliana O Mara, PharmD August 4, 2018 Objectives Review the pathophysiology of hypotension in neonates Discuss the role of vasopressors
More informationDIASTOLIC HEART FAILURE
DIASTOLIC HEART FAILURE M Mohsen Ibrahim, MD Alexandria, Proposed Criteria for Diastolic Heart Failure ESC Working Group (EHJ 1998) CHF signs/symptoms EF 45% Hemodynamic or echo evidence of diastolic dysfunction
More informationInnovation therapy in Heart Failure
Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure
More informationWhat s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE. Marc Ferrini (Lyon Fr)
What s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE Marc Ferrini (Lyon Fr) Palermo (I) 1 04 2017 Consulting Fees, Honoraria: BAYER PHARMA BOEHRINGER INGELHEIM BRISTOL MEYERS
More informationThe challenge of treating a stiff heart
ResearchFeatures.com The challenge of treating a stiff heart Heart failure, when the heart fails to pump blood properly around the body, hospitalises more people in the Western world than any other condition.
More informationSudden cardiac death: Primary and secondary prevention
Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)
More informationWelcome to the Exhibitor Tutorial presented by
Welcome to the Exhibitor Tutorial presented by February 1, 217 1 Calcium Handling Assays with Human ipsc-derived Cell Types Coby Carlson, Ph.D. 7 February 217 Transformative Potential of ipsc Technology
More informationAtrial dysfunction and chronotropic incompetence
Pathophysiology of heart failure with preserved ejection fraction Atrial dysfunction and chronotropic incompetence Vojtech Melenovsky IKEM, Prague, Czech Republic DECLARATION OF CONFLICT OF INTEREST :
More informationChanges in myocardial excitation-contraction coupling are
Excessive Sarcoplasmic/Endoplasmic Reticulum Ca 2 -ATPase Expression Causes Increased Sarcoplasmic Reticulum Ca 2 Uptake but Decreases Myocyte Shortening Nils Teucher; Juergen Prestle, PhD; Tim Seidler,
More informationHeart Failure Update John Coyle, M.D.
Heart Failure Update 2011 John Coyle, M.D. Causes of Heart Failure Anderson,B.Am Heart J 1993;126:632-40 It It is now well-established that at least one-half of the patients presenting with symptoms and
More informationUremic Cardiomyopathy with a focus on the role of α-klotho and FGF23
Uremic Cardiomyopathy with a focus on the role of α-klotho and FGF23 Marc G Vervloet, MD, PhD, FERA VU university medical center Amsterdam, The Netherlands Disclosures Scientific support AbbVie, Amgen,
More information